Latest News from: Association for Molecular Pathology

Filters close
Released: 19-Apr-2022 1:25 PM EDT
Report Offers Recommendations to Improve Clinical Testing Economics and Inform National Preparation Strategies for Future Public Health Emergencies
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) today released a report entitled “Economics of Clinical Testing during a Public Health Emergency: Lessons Learned from Two Years of COVID-19.” The detailed assessment reflects on the first two years of the COVID-19 pandemic, dissects various coding, coverage, and pricing policies, and provides 15 recommendations to help prevent or at least mitigate these same economic challenges in the future.

Released: 5-Apr-2022 1:05 PM EDT
Association for Molecular Pathology Hosted a Congressional Briefing to Urge Lawmakers to Consider the VALID Act of 2021 Separately from the Medical Device User Fee Agreement Process
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, called on Congress to allow for a thorough evaluation of the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, or any other legislation to change regulations for laboratory developed testing procedures (LDPs). Representatives from AMP, the American Association for Clinical Chemistry (AACC), the American College of Medical Genetics and Genomics (ACMG), and the Association of Pathology Chairs (APC) hosted a congressional briefing yesterday to educate lawmakers about how diagnostic tests are currently regulated and the substantial impact the VALID Act would have on clinical testing laboratories, healthcare providers, and patients throughout the U.S.

Released: 9-Feb-2022 11:20 AM EST
Association for Molecular Pathology and The American Society for Investigative Pathology Announce New Editor-in-Chief for The Journal of Molecular Diagnostics
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostics professional society, today announced the appointment of Ronald M. Przygodzki, MD as the incoming Editor-in-Chief of The Journal of Molecular Diagnostics (JMD). Barbara Zehnbauer, PhD, who has served with distinction as Editor-in-Chief since January 2015, will retire from the position effective March 1, 2022.

Released: 1-Nov-2021 4:05 PM EDT
Association for Molecular Pathology Announces 2021 Award Recipients
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostics professional society, today announced the recipients of this year’s Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award.

Released: 1-Nov-2021 3:05 PM EDT
Association for Molecular Pathology Leaders Publish Recommendations to Improve Diagnostic Testing Response for Current COVID-19 Pandemic and Future Emerging Outbreaks
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today announced a new article in JAMA Health Forum.

Released: 29-Jul-2021 10:40 AM EDT
AMP Publishes Recommendations to Facilitate Widespread Adoption of Genetic Variant Data Sharing Practices
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) today released recommendations to support and facilitate sharing of variant data through the use of public repositories.

Released: 10-Jun-2021 1:00 PM EDT
AMP Recommends Minimum Set of Pharmacogenetic Alleles to Guide Clinical CYP2D6 Genotype Testing, Promote Standardization, and Improve Patient Care
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP2D6 assays, promote standardization of testing across different laboratories and improve patient care. The manuscript, “Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and European Society for Pharmacogenomics and Personalized Therapy,” was released online ahead of publication in The Journal of Molecular Diagnostics.

Released: 18-May-2021 1:00 PM EDT
Association for Molecular Pathology and Association of Pathology Chairs Call on Congress to Pass the Verified Innovative Testing in American Laboratories (VITAL) Act
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) and the Association of Pathology Chairs (APC) commend U.S. Senator Rand Paul (R-KY) for introducing legislation that would allow molecular pathology professionals to continue advancing and offering high-quality laboratory developed testing procedures (LDPs) for patient care. The Verified Innovative Testing in American Laboratories (VITAL) Act of 2021 would enhance transparency, preserve innovation, and ensure widespread patient access to essential medical services.

16-Mar-2021 10:00 AM EDT
New Association for Molecular Pathology Report Reignites Effort for Appropriate Reimbursement for Professional Analysis, Interpretation, and Reporting of Molecular Diagnostic Testing Procedures
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) has released the results of its qualitative and quantitative “Analysis of Professional Work Effort in Molecular Test Interpretation Report.” More than 100 molecular professionals reported that their efforts spent on data analysis, interpretation, and reporting for molecular diagnostic tests were not sufficiently reimbursed. Respondents indicated that adequate reimbursement for these activities would improve patient care by increasing access to these essential medical services and enabling more data-driven treatment decisions.

Released: 23-Feb-2021 10:45 AM EST
Latest Association for Molecular Pathology Survey Findings Indicate Significant Decline in Molecular Testing for Cancer During COVID-19 Pandemic
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the preliminary results of its “Molecular Testing for Cancer during COVID-19” survey of clinical laboratories.

Released: 26-Jan-2021 10:05 AM EST
Association for Molecular Pathology Reinforces Continued Commitment to Improving National Diagnostic Testing Response for Current COVID-19 Pandemic and Future Emerging Outbreaks
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today announced the formation of the AMP COVID Response (ACR) Steering Committee to help coordinate and communicate the organization’s continued efforts to guide diagnostic testing during the ongoing COVID-19 pandemic and preparations for future emerging outbreaks.

Released: 8-Oct-2020 12:05 PM EDT
Association for Molecular Pathology Releases Preliminary Results to Second 2020 Nationwide SARS-CoV-2 Molecular Testing Survey
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) has released the preliminary results of its August 2020 SARS-CoV-2 Testing Survey for clinical laboratories. Respondents are experiencing continued supply chain interruptions and significant staffing shortages, all while demand for molecular diagnostic testing continues to increase.

Released: 10-Sep-2020 12:05 PM EDT
Association for Molecular Pathology Announces 2020 Award Recipients
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostics professional society, today announced the recipients of this year’s Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award.

Released: 21-Aug-2020 9:50 AM EDT
AMP Commends Department of Health and Human Services on Decision to Lessen Regulatory Burden on Laboratory Professionals
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostics professional society, commends the decision by the U.S. Department of Health and Human Services (HHS) to rescind the requirement for premarket review of laboratory developed testing procedures (LDPs) by the Food and Drug Administration (FDA).

Released: 28-May-2020 8:00 AM EDT
Association for Molecular Pathology Releases Preliminary Results to Nationwide SARS-CoV-2 Molecular Testing Survey
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the preliminary results of its April 2020 SARS-CoV-2 Testing Survey for clinical laboratories. The anonymous survey was created and administered to document clinical laboratory efforts and experiences. The results will be used to help inform future advocacy and clinical practice programs related to pandemic responses.

Released: 5-May-2020 3:40 PM EDT
AMP Recommends Minimum Set of Pharmacogenetic Alleles to Help Standardize Clinical Genotyping Testing for Warfarin Response
Association for Molecular Pathology

AMP has published consensus, evidence-based recommendations to aid in the design, validation and interpretation of clinical genotyping tests for the prediction of warfarin response. The manuscript, “Recommendations for Clinical Warfarin Sensitivity Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists,” was released online ahead of publication in The Journal of Molecular Diagnostics.

Released: 4-May-2020 12:55 PM EDT
AMP Expresses Support for Citizen Petition from the Coalition to Preserve Access to Pharmacogenomics Information
Association for Molecular Pathology

AMP has submitted a formal response in support of the Citizen Petition from Hyman, Phelps & McNamara, P.C. on behalf of the Coalition to Preserve Access to Pharmacogenomics (PGx) Information. The response builds on AMP’s PGx Best Practices Statement and includes a series of recommendations that will rectify recent FDA actions, which have suppressed important patient safety information.

Released: 18-Mar-2020 9:50 AM EDT
Association for Molecular Pathology Commends Senator Rand Paul for Introducing theVerified Innovative Testing in American Laboratories (VITAL) Act of 2020
Association for Molecular Pathology

AMP applauds US Senator Rand Paul (R-KY) for introducing new legislation to allow molecular pathology professionals to continue advancing and offering laboratory developed testing procedures (LDPs) for patient care. The Verified Innovative Testing in American Laboratories (VITAL) Act of 2020 clarifies the federal regulatory authority over LDPs and encourages the modernization of the existing Clinical Laboratory Improvement Amendments (CLIA), which are administered by the Centers for Medicare and Medicaid Services(CMS). The legislation was designed to enhance transparency, preserve innovation and ensure widespread patient access to essential medical services.

   
Released: 16-Mar-2020 9:00 AM EDT
Association for Molecular Pathology Calls on Senate to Close Coverage Gaps for Clinical Laboratory Testing in Families First Coronavirus Response Act
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released a statement on H.R. 6201, the Families First Coronavirus Response Act, as passed by the House of Representatives on March 14, 2020.

Released: 19-Sep-2019 9:00 AM EDT
Association for Molecular Pathology Announces 2019 Award Recipients
Association for Molecular Pathology

AMP has announced the recipients of this year’s Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award. These prestigious accolades will be presented this November during AMP’s 25th Annual Meeting & Expo in Baltimore, Maryland.



close
0.12807